Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas

Objective This study aims to calculate the global warming potential, in carbon dioxide (CO2) equivalent emissions, from all in-scope activities involved in phase 1, 2, 3 and 4 clinical trials spanning multiple disease areas.Design The study design involved a retrospective analysis of completed clini...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Collins, Thomas Costelloe, Jason Keith LaRoche, Rodrigo Alvarenga, Wouter De Soete, Jeremy Faludi, Kristel Rens, Jason Lanier, Annemie Chiau, Hugh Whetherly
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/2/e085364.full
Tags: Add Tag
No Tags, Be the first to tag this record!